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This review focuses on recent developments in the molecular mechanisms by which Ca activates cardiac sarcomeres and how
these mechanisms play out in the cardiac cycle. I emphasize the role of mechanisms intrinsic to the sarcomeres as signiﬁcant
determinants of systolic elastance and ventricular stiﬀening during ejection. Data are presented supporting the idea that processes
intrinsictothethinﬁlamentsmaypromotecooperativeactivationofthesarcomeresandbeanimportantfactorinmaintainingand
modifying systolic elastance. Application of these ideas to translational medicine and rationale drug design forms an important
rationale for detailed understanding of these processes.
1.Introduction
One of the signiﬁcant challenges to investigations of control
mechanisms in cardiac contraction and relaxation is the
understanding of the relation between the molecular and
cellular biology of working ventricular myocytes and the
dynamics of the heart beat. There is wide acceptance that the
transition from diastole to systole requires electrochemical
coupling involving a membrane controlled release of Ca2+
into the sarcoplasmic space [1]. The rise in intracellular Ca2+
induces chemomechanical coupling in which Ca-binding
to cardiac troponin C (cTnC) triggers a series of protein-
protein interactions releasing the thin ﬁlaments from inhibi-
tion and promoting a force generating interaction between
myosin cross-bridges and actin. The rise in intracellular
Ca is transient as highly eﬀective processes actively trans-
port the Ca2+ back into cellular storage depots within
the sarcoplasmic reticulum or back to the extra-cellular
space. Thus, chemomechanical uncoupling has generally
been considered to occur by a fall in intracellular Ca2+,
release of Ca2+ from cTnC, waning of the actin-cross-bridge
reaction, and a return of the myocytes to their diastolic
state. In relating these molecular and cellular processes to the
heart beat, there has been much focus on the idea that the
dynamics are determined largely by the amounts and rates of
movements of Ca2+ to and from the sarcomeres. A natural
and understandable extension of this idea is that variations
in the amounts of Ca2+ released to the sarcomeres largely
determine contractility.
However, this perspective ignores the signiﬁcant role
of processes intrinsic to the sarcomeric proteins as deter-
minants of the dynamics of the heart beat and as a
controlled variable determining contractility. Early studies
demonstrated that switches in isoform population of the
myosin heavy chain have signiﬁcant eﬀects on dynamics
of the heart beat independent of altered Ca2+ ﬂuxes. More
recent studies have demonstrated that isoform switches,
posttranslational modiﬁcations, and mutations in sarcom-
eric proteins may also aﬀect cardiac dynamics apart from
membrane controlled alterations in cellular Ca2+ ﬂuxes [2,
3]. It is alsosigniﬁcant that the emphasis on Ca2+ asthemain
determinantofalteredcontractilityisbasedlargelyonstudies
with unloaded cardiac myocytes in which intracellular
Ca-transients and shortening are determined. The critical
question, however, is how do these molecular events relate in
timetotheheartbeatinwhichpressureﬁrstdevelopswithno
change in volume then pressure is sustained while ejection is
ongoing and volume is decreasing, and ﬁnally pressure falls2 Journal of Biomedicine and Biotechnology
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Figure 1: Structure of a patch of cardiac thin ﬁlament demonstrating the position of troponin components with tropomyosin (Tm) in the
“oﬀ” state. (a) Thin ﬁlament containing, only troponin I (cTnI) and troponin C (cTnC). cTnC is shown as a dumbbell shaped protein with
the N-lobe containing a single regulatory Ca-binding site. cTnI is shown tethered to actin on an actin strand by an inhibitory peptide (Ip)
and a second actin binding region ﬂanking a switch peptide (Sw), which interacts with cTnC upon Ca-activation. The distal C-terminal
end of cTnI drapes across azimuthal actins and may interact with Tm. cTnI has a unique stretch of N-terminal amino acids, which contain
phosphorylation sites at S23, S24. The N-peptide interacts with the N-lobe of cTnC, but is released upon phosphorylation and may react
with the Sw or Ip of cTnI. (b) Thin ﬁlament contains the complete Tn complex. Note that the Ip of cTnI binds to one actin strand, whereas
the N-terminal tail of troponin T (cTnT) interacts with Tm on the adjacent actin strand. The consequence is that Tm is wedged and held in
a blocking position.
with no change in volume. What we need to know is how
do the Ca2+ transients change in an ejecting beat, where is
the Ca2+ bound during this time, and how does free and
bound Ca2+ change with physiological, pathophysiological,
and pharmacological manipulations of cardiac function. We
need to fully integrate processes upstream and downstream
toCa-bindingtocTnCandtoknowtheirrelativesigniﬁcance
in these manipulations.
In the present review, I focus on the molecular and
cellular events in the ventricular heart beat that occur after
Ca2+ binds to cTnC and induce conformational changes in
the thin and the state of the thin and thick ﬁlaments after
Ca2+ is released from cTnC. I discuss a current view of the
molecular interactions among sarcomeric proteins responsi-
ble for the transition from diastole to systole and potential
mechanisms by which activation of the actin-cross reaction
may be sustained by cooperative processes in sarcomeric
activation.Ialsopresentrecentdevelopmentssupporting the
hypothesis that sarcomeric proteins are eﬀective targets for
inotropic agents useful in cardiac disorders including heart
failure.
2. Promotion of the Actin-Cross-Bridge
Reaction by On-Off Control of the Troponin
Ca-Switch
Ca-binding to cTnC engages a remarkable and complex set
of protein-protein interactions that result in the release of
the thin ﬁlament from an inhibited state and in a force
generating interaction between the myosin cross-bridge and
actin. These interactions provide many potential control
points for regulation of the sensitivity and steepness of the
response to Ca2+, as well as force, ATPase rate, and cross-
bridge kinetics at a given level of bound Ca2+. Recent studies
[4–7] continue to illuminate these interactions and provide
new perspectives.
Figure 1 illustrates a portion of a structural unit of the
thin ﬁlament (7 actins in 1:1:1:1 complex with tropomyosin
(Tm), troponin C (cTnC), troponin I (cTnI), and troponin
T (cTnT). Figure 1 includes a current perception of these
interactions based on evidence from the core crystal struc-
ture of cardiac troponin (Tn) [8], from elucidation of the
structures by NMR [9], from biochemical investigations of
protein-protein interactions [10–12], and from reconstruc-
tions and single particle analysis from electron micrographs
of reconstituted myoﬁlament preparations [5]. To clarify the
relatively recent updates and new concepts in the structure
functions relations, Figure 1 (a) shows only the cTnI and
cTnC (with Ca2+-bound to two C-terminal lobe structural
sites)componentsbindingtoanactin-tropomyosinstrandin
the thin ﬁlament. Figure 1 (b) adds cTnT and illustrates new
data demonstrating that the N-terminal tail of cTnT binds to
an actin strand opposite to that to which cTnI-cTnC binds.
Figure 1(a) depicts cTnI and cTnC in the thin ﬁlament based
on the core crystal structure of cTn. The crystal structure
did not resolve signiﬁcant regions including an inhibitory
peptide (Ip), which tethers cTnI to actin, and the unique
N-terminal peptide (∼30amino acids). The structure of
these regions is based on biochemical evidence including
determination of protein-protein interactions, ﬂorescence
energy transfer, and NMR solution structure determinationJournal of Biomedicine and Biotechnology 3
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Figure 2: Alterations in thin ﬁlament structure and promotion of the actin-cross-bridge reaction induced by Ca2+-binding to cTnC. The
left panel shows the diastolic state as in Figures 1 and 2. The right panel shows the systolic state and illustrates the release of cTnI from
actin and binding of the switch peptide to cTnC most likely at a hydrophobic patch induced by Ca2+ -binding to the N-lobe of cTnC. cTnT
from the Tn complex on the adjacent actin strand is shown with stripes. Activation is associated with release of Tm from an immobilized
state by protein signaling to cTnT and possible release of Tm from an interaction with the C-terminal end of cTnI. See text for further
description.
(reviewed in [10]). Figure 1(a) illustrates an oﬀ state with
binding of cTnI to actin via two regions, a highly basic
inhibitory peptide (Ip) and a second actin binding region.
Importantly these regions ﬂank a “switch peptide.” New
data provide evidence for a role of the cTnI C-terminal
mobile domain in the oﬀ state. This C-terminal domain has
been demonstrated to bind to azimuthally localized actins
with the far cTnI C-terminus lying across Tm [4]. Direct
biochemical evidence for an interaction between this region
of TnI and Tm has been reported by Mudalige et al. [13],
who employed photochemical cross- linking studies with Tm
labeled at positions 146 or 174. Their data indicate a cross-
linking of Tm-146 with fast skeletal TnI (fsTnI) peptide 157-
163 (DVGDWRK), which corresponds to a nearly identical
C-terminal peptide in the cTnI (EVGDWRK). Importantly
this study also demonstrated that the cross-linking between
Tm and fsTnI occurred only under low Ca2+ conditions,
whereas cross-linking of Tm-174 to TnT was not Ca2+-
dependent. This interaction may be critical to control of
thin ﬁlament activation state and provides a mechanism
for earlier observations indicating a signiﬁcant role for the
far C-terminal peptide of cTnI [14, 15] in thin ﬁlament
activation. Figure 1(b) illustrates the position of cTnT in
the thin ﬁlament complex with the C-terminal regions
interacting together with the near N-terminal region of
cTnI and the C-terminal lobe of cTnC. cTnT is the main
anchor site of the Tn complex to Tm. Sites of interaction
occur between N-terminal regions of cTnT and Tm-175-
190 and Tm-258-284 [10, 11, 16]. Figure 1(b) shows a new
concept of the interaction of cTnT with the thin ﬁlament
based on predictions reported by Galinska-Rakoczy et al.
[4]. This study predicted that the N-terminal extension
of cTnT binds to the strand of actins opposite to that
binding the main core Tn complex. Thus, as described
[4] and illustrated in Figures 1 and 2,T mi sw e d g e di n
the blocking position between the cTnI mobile domain on
one side and the troponin core domain and TnT on the
other. Thus the oﬀ state of the thin ﬁlament involves an
immobilized Tm blocking the actin cross-bridge reaction.
Immobilization of Tm involves anchoring of cTnI to actin as
well as interactions between the N-terminal tail of TnT with
Tm and possibly the C-terminal mobile domain of cTnI with
Tm.
Figure 2 shows the transition in myoﬁlament state with
Ca2+ binding to cTnC. With its release into the intracellular
space, Ca2+ binds to cTnC at a single site in the N-lobe
and promotes the “on” state by inducing the generation
of a hydrophobic patch, which draws the cTnI switch
peptide to cTnC. This critical event in the on-oﬀ switching
mechanisms releases the thin ﬁlament from inhibition by
movements of the Ip and second actin binding site of cTnI
from actin. The Ca-binding signal also induces a release
of TnT from its interaction from Tm. These Ca-induced
alterations in thin ﬁlament protein-protein interactions
result in transition of Tm from a relatively immobilized
state to a mobile state permitting the reaction of cross-
bridgeswithactin.Thepropensityofinteractionofthecross-
bridges with actin is also governed by the relative radial
positionofthecross-bridgewithrespecttothethickﬁlament
proper. As discussed below there is compelling evidence
that regulatory mechanisms control this radial movement
of cross-bridges. These regulatory mechanisms involve thick
ﬁlament associated proteins, myosin light chain 2 (MLC2)
[17], myosin binding protein C (MyBPC) [18], and titin
[19].
3. Modulation of the Troponin Ca
2+ Switch
To illustrate modulation of the Ca2+ switch I discuss
phosphorylation of cTnI. A major region of phosphory-
lation is the cTnI-N-terminal peptide, which is unique to
the cardiac isoform. I have reviewed the multiple kinases
controlling sarcomeric protein phosphorylation elsewhere4 Journal of Biomedicine and Biotechnology
[12]. Figure 1(a) indicates an interaction of the N-terminus
of cTnI, which contains 2 prominent phosphorylation sites,
whicharesubstratesforPKA,PKG,PKD,andPKC-δ [12].As
discussed below this interaction is an important determinant
of the aﬃnity the cTnC N-lobe for Ca2+. Figure 1 also shows
interactions of the unique N-terminal peptide of cTnI with
the N-lobe of cTnC. This interaction is strong when the N-
peptide is not phosphorylated at Ser 23, Ser 24, but with
phosphorylation at these sites the N-peptide is released from
cTnC [20]. The release of the peptide induces a signiﬁcant
depression in Ca-aﬃnity of cTnC [21] and appears to
promote an increase in kinetics of the actin-cross bridge
reaction [22, 23]. These eﬀects together with adrenergic
control of Ca ﬂuxes are important aspects of the tuning of
the contraction relaxation cycle of the heart to altercations
in heart rate. On the basis of NMR determination of the
solutionstructureontheN-peptideofcTnI,wehypothesized
that this peptide, which has negatively charged residues,
mightinteractwiththepositivelychargedregionsofthecTnI
Ip [9, 24]. We tested this possibility employing a hetero-
bifunctional cross linker linked to a Cys residue engineered
into position 5 of cTnI normally containing Ser 5 and
into position 19 normally containing an Iso residue [24].
Our data demonstrated an intermolecular interaction with
positions Met-47 and Met-80 ofcTnC and anintramolecular
interaction between the N-peptide of cTnI and cTnI at
Met-154 (I19C mutant) and Met-155 (S5C mutant). Met
154 and Met 155 are residues located in the cTnI switch
peptide, and thus we hypothesized that this interaction may
be a critical regulatory device and dependent on the charge
state of the cTnI N-peptide. The hypothesis needs to be
further tested by experiments employing other probes of
conformation changes suchas ﬂuorescenceresonance energy
transfer and electron spin resonance. Other prominent and
unique sites of phosphorylation of cTnI are Thr 144 in
the Ip and Ser 43, Ser 45 in a near N-terminal region
of cTnI, which interacts with the C-lobe of cTnC and
C-terminal regions of cTnT [10, 12]. Phosphorylation of
Thr 144 has been demonstrated to either enhance Ca2+
sensitivity or have little eﬀect, whereas phosphorylation
of Ser 43/Ser 45 has been reported to depress maximum
tension and Ca2+ sensitivity of skinned ﬁber preparations.
Phosphorylation of these sites has also been reported to slow
down velocity of thin ﬁlament sliding in the motility assay,
whereas phosphorylation of cTnI Ser 23/Ser 24 enhances
sliding velocity [10].
4.The Time Courseof SystolicElastance
andRatesof IsovolumicRelaxationReﬂect
Mechanismsatthe Levelof
Sarcomeric Proteins
RelatingthemolecularmechanismssummarizedinFigures1
and2tothecardiaccycleespeciallyinlargeanimalsremainsa
signiﬁcantchallenge,whichiscriticalintranslationalstudies.
Figure 3illustratesthecardiaccyclesimplybythetimecourse
of the change in left ventricular pressure during an ejecting
beat in basal conditions in a dog heart. The time course
0
20
40
60
80
100
120
0 100 200 300
0
20
40
LVP
Ca-Tn
L
V
P
(
m
m
H
g
)
C
a
-
T
n
-
T
m
-
a
c
t
i
n
Time (ms)
Onset End
Ejection
Figure 3: Relation between left ventricular pressure changes during
the cardiac cyle and Ca2+-binding to cTnC in the myoﬁlament
lattice. The onset and end of ejection are indicated. Note that
pressure (systolic stiﬀening or elastance) is maintained despite
the fall in bound Ca2+.T h eC a 2+ binding kinetics are based on
computations described Burkhoﬀ and colleagues [25, 26]. See text
for further discussion.
of the beat serves to constrain theories relating the cellular
and molecular mechanisms of contraction and relaxation.
Studies employing hearts loaded with Ca-sensitive dyes such
as Rhod 2 and use of ﬁber optic directed excitation, and
emission measurements have been carried out to determine
the time course of cellular Ca2+ transients in a heartbeat
[27, 28]. However, these studies have employed isovolumic
rodent hearts. It is not clear therefore how the time course
of the Ca2+ transient relates to the time course of systolic
elastance in a beating ventricle. Even so, studies of Ca2+
transients and isometric force generation reveal that the
duration of the Ca2+ transient is faster than the duration
of force development [25, 29]. The critical dynamic is the
time course of Ca2+-binding to cTnC during a beat of the
heart. Unfortunately, we do not have measurements of the
amountsofCa2+ boundtothemyoﬁlamentsduringtheheart
beat. Early and more recent studies have demonstrated that
the only site capable of exchanging Ca2+ during the beat is
the single regulatory binding site on the N-lobe of cTnC
(Figure 2). As illustrated in Figure 3, indirect estimations
[30] and computations [25, 26] based on rate constants of
Ca2+ exchange with cTnC indicate that, as expected, the
Ca-binding increases with the transition from diastole to
systole, but these same computations also indicate that cTnC
bound Ca may decrease signiﬁcantly during maintenance of
systolic elastance and ahead of isovolumic relaxation. The
data illustrated in Figure 3 have important consequences
with regard to our understanding of physiological control
of ejection, its modiﬁcation in cardiac disorders, and in
approaches to alterations in sarcomeric function by drug
targeting. Moreover if Ca2+-binding and the Ca2+-transient
are essentially over at the end of ejection and closureJournal of Biomedicine and Biotechnology 5
of the atrioventricular valves this means that isovolumic
relaxationandre-establishmentofthediastolicstatedepends
on mechanisms intrinsic to the myoﬁlaments. Hinken and
Solaro [3] have previously discussed this disparity and
potential mechanisms by which systolic elastance might be
maintained in the face of a declining Ca2+ transient and
cTnC bound Ca2+. The mechanisms involve a cooperative
activation of the thin ﬁlaments in which Ca2+ binding
to a cTnC on the thin ﬁlament promotes activation of
near neighbor units. However, recent evidence has provided
highly relevant and new perspectives on the cooperative
processes, and on the modiﬁcations in the myoﬁlaments
that may modulate elastance [4–7]. These control processes
intrinsic to the myoﬁlaments are also of signiﬁcance in
preload (sarcomere length) sensing and engagement of
immediateresponsesintermsoftheFrank-Starlingrelations.
Intrinsic myoﬁlament mechanisms also are important in
sensing the load in a negative feedback mechanism related
to the force-velocity relation and in power generation [31,
32], and also in the relaxation kinetics related to rates of
cross-bridge detachment and intersarcomere dynamics (as
described by Pogessi et al. [33]).
5. Thin andThick FilamentMechanisms
Relatedto Maintenanceof SystolicElastance
Cooperative activation of cardiac myoﬁlaments has long
been appreciated as a signiﬁcance aspect of control of cardiac
function including diastolic ﬁlling, the triggering and sus-
tainingofdevelopedpressure,andthedynamicsofrelaxation
[10, 34]. Strong evidence for this cooperativity comes from
measurements of the steady-state relation between free Ca2+
and force generation in detergent extracted single myocytes
or bundles of myocytes. Despite control of activation by a
single regulatory site on cTnC, the force-Ca2+ relations are
steep and are commonly ﬁt with Hill coeﬃcients in the range
of 3–5 [35]. Moreover as mentioned above in presteady state
measurements of the relation between the duration force
generation in ﬁber preparations, the dynamics of the Ca2+
transient show that the decline if the Ca2+ transient occurs
well ahead of the Ca2+-transient.
Interactionsamongproteinswithinafunctionalunitand
among the functional units of the sarcomere form the basis
of the most prominent theories for the mechanism of the
steep dependence of force on Ca2+. These interactions are
illustrated in Figure 4. What promotes these interactions is
under current debate. Detailed balance drives one of the
theories in which the energies of interaction between cTnC
and the actin-myosin interface ﬂows in both directions.
That is, the promotion of the actin-myosin interaction
by Ca2+ signaling through cTnC in turn promotes Ca2+
binding to cTnC [10, 16, 34]. For example, in steady-
state measurements of the Ca2+-force relation in skinned
ﬁbers, as more force generating cross-bridges react with
the thin ﬁlament with increases in Ca2+, this theory pre-
dicts an increase in the aﬃnity of cTnC also increases.
Longitudinal spread of activation along the thin ﬁlament
forms the basis for a second theory. The mechanism for
TnT-N-term
(from opposite
actin strand)
Tm-
overlap
cTnI-Ip
Figure 4: View of an extended region of a functional unit of
the thin ﬁlament illustrating the position of the Tn complexes
and the possible interactions among contiguous functional units.
Cooperative spread of activation of one region of the thin ﬁlament
may occur by actin-actin interactions or by spread via Tm overlap.
Color coding of proteins as in Figure 2.
the longitudinal spread remains a matter of debate. There
are data demonstrating that strongly bound (rigor) cross-
bridges are able to move Tm away from the cross-bridge
binding sites on actin and closer to the groove in the actin
helix [5]. Contiguous Tms overlap forming a continuous
molecular strand believed to sensitive to this cross-bridge
induced movement of Tm (Figure 4). Thus, in this theory
activationspreadstoanearneighborfunctionalunitwithout
the need for Ca2+ binding to the cTnC in that unit. One
of the issues with the theories described above is that they
are based on measurements of Ca2+-binding and spread of
activation in which nucleotide free (rigor) cross-bridges or
cross-bridges modiﬁed with NEM are used as a surrogate for
the strongly interacting and force generating cross-bridge.
These cross-bridges strongly react with the thin ﬁlament
but do not cycle and generate tension. Recent direct tests
have failed to demonstrate that force generating, cycling
cross-bridges promote molecular modiﬁcations in the thin
ﬁlament in the same way as to rigor cross-bridges. One
set of studies involved measurements of Ca2+ binding to
the regulatory site of cTnC in reconstituted thin ﬁlaments
alone or reacting with nucleotide-containing or nucleotide
free cross-bridges in the form of myosin-S1[36]. The data
are summarized in Table 1. A signiﬁcant ﬁndings in these
data are that Ca2+ binding to the single regulatory site is
cooperative (nH = 1.65) in the presence and absence of
nucleotide bound myosin S-1. Moreover, reaction of the thin
ﬁlaments with nucleotide-free S-1 increased Ca2+-aﬃnity as
predicted from previous studies, with a signiﬁcant decrease
in cooperativity (nH = 0.85). These data indicate that6 Journal of Biomedicine and Biotechnology
Table 1: Strong binding rigor cross-bridges but no cycling cross-
bridges aﬀect Ca-binding to troponin C in reconstituted myoﬁla-
ment preparations. Data are from Davis et al. [36].
System Kd nM Hill n Koﬀ(/s)
Thin Filament 4810 ±300 1.65 ±0.04 105 +1
Thin Filament + S1 777 ±30 0.81 ±0.02 13 ±.1
Thin Filament + S1 + ATP 5040 ±400 1.65 ±0.08 110 ± 1
cooperativeactivationofmyoﬁlamentsreliesonmechanisms
intrinsic to the thin ﬁlaments. Studies probing thin ﬁlament
activation by use of ﬂuorescent probes at speciﬁc sites
on cTnC support this concept [6, 7]. cTnC labeled with
probes sensing the “on” state and incorporated into skinned
ﬁber preparations, tracked the Ca2+-force relation and show
a similar cooperative response. The relation between the
“on” states of cTnC remained the same when the cross-
bridge interactions were completely blocked with blebbis-
tatin. Thus these results indicate that the promotion of
near-neighbor interactions along the thin ﬁlament do not
require force generating cross-bridges. These results alter
thinking with regard to the relative roles of cycling and rigor
cross-bridges. There may be some eﬀects of cycling cross-
bridges on cooperative activation of the thin that are more
apparent in presteady state measurements, but evidence
of the relative low numbers of interacting cross-bridges
during contractions suggests that this would be a minor
inﬂuence. On the other hand in conditions of compromised
generation of ATP and the elaboration of nucleotide free
cross-bridges, there would be an inﬂuence on activation.
Thus, the current evidence does not dismiss eﬀects of rigor
cross-bridges on myoﬁlament activation, but relegates this
mechanism to a patho-physiological role as in ischemia
and cardiomyopathies rather than in physiological control
mechanisms.
6. Signalingto CardiacSarcomeres and
ControlofCooperativeActivation
Modiﬁcations in thin ﬁlament proteins appear to aﬀect
cooperative spread of activation induced by force generat-
ing and rigor cross-bridges. Cross-bridge dependent thin
ﬁlament activation depends on the isoform population of
TnI. In myoﬁlaments regulated by slow skeletal TnI (ssTnI),
the ability of rigor and NEM-modiﬁed cross-bridges to
activate force generation in the absence of Ca2+ was less
than in the case of myoﬁlaments controlled by cTnI [37].
This diﬀerence was particularly evident at acidic pH and
evidence was developed to implicate a role. His residue at
position 34 in ssTnI. When His-34 was replaced by Ala,
which is the residue at the homologous position (Ala-66)
in cTnI, activation by rigor cross-bridges was similar to
that of myoﬁlaments controlled by cTnI. These ﬁndings led
us to compare cross-bridge dependent activation in cardiac
myoﬁlaments controlled either by wild type cTnI or by
cTnI-A66H. When pH was reduced from pH 7.0 to pH
6.5, there was enhanced cross-bridge-dependent activation
in cTnI myoﬁlaments, but depressed activation in cTnI
(A66H) myoﬁlaments. These data may be of signiﬁcance
in our ﬁnding that compared to wild-type controls that
adult hearts expressing ssTnI demonstrate protection against
the stress of ischemia and reperfusion, where rigor cross-
bridges are likely to be present [38]. In view of evidence that
ischemia is associated with activation of protein kinase C
(PKC), Engel et al. [39] also compared the ability of NEM-
S1, a mimic of rigor cross-bridges to activate control cardiac
myoﬁlamentsregulatedbycTnIandmyoﬁlamentscontrolled
by cTn complex containing either cTnI-(S43E/S45E) or
cTnI-(T144E). These pseudo-phosphorylated sites are pre-
dominant PKC sites in Tn. Our data show that compared to
controls, the myoﬁlaments controlled by cTnI-(S43E/S45E)
demonstrated a signiﬁcant reduction in the ability of NEM-
S1 to recruit cycling cross-bridges. Pseudo-phosphorylation
of cTnI-(T144) had similar but less extensive eﬀect. The
functional signiﬁcance of the modiﬁcations in Tn may be
important in sparing energy consumption in ischemia.
Studies with transgenic models expressing cardiac spe-
ciﬁc and pseudo-phosphorylated mutants of cTnI (cTnI-
S43E, S45E, T144E) also provide evidence of the signiﬁcance
of potential thin ﬁlament related cooperative mechanism
[40]. In these studies extensive two-dimensional gel analysis
demonstrated replacement of the endogenous cTnI with
only 7.2 ± 0.5% of the mutant. Even with this modest
increase in PKC-dependent phosphorylation, data from
studies with perfused hearts, and intact and skinned myocar-
dial preparations showed an induction of highly signiﬁcant
depressions in pressure and force generation with no change
in Ca2+ transients. There were also signiﬁcant depressions
in relaxation rates. Mathematical modeling revealed that
these eﬀects are likely to be induced by a simultaneous
reduction in the rate of cross-bridge entry into the force
generating state, and by an increase in Ca2+ -independent
persistence of the myoﬁlament active state. Whatever the
case, these data indicate that the small number of modiﬁed
TnI proteins in the hearts of the transgenic mice expressing
the mutant protein must be able to inﬂuence their neighbors
on the thin ﬁlament. Eﬀects of the expression of the pseudo-
phosphorylated cTnI on systolic elastance and isovolumic
relaxation have not as yet been carried out.
Modiﬁcations in thick ﬁlament proteins especially
MyBP-C and MLC2 appear especially important in aﬀecting
systolic elastance. In comparing various transgenic models
Palmer et al. [41] reported that only the hearts of the
cMyPP-C t/t mice demonstrated a signiﬁcant change in
stiﬀening during ejection. Whereasthecontrolsreached42%
of maximum elastance at the onset of ejection, the t/t mutant
hears reached 77% of peak elastance. Moreover, elastance
peaked earlier and was abbreviated in hearts of the cMyBP-C
t/t mice compared to controls. Thus these data indicate that
normal cardiac function and duration of systolic elastance
rely on the integrity of MyBP-C. Scruggs et al. [17] have also
generated evidence indicating the phosphorylation of MLC2
may be an important factor in determining the duration of
systolic elastance. The states of both MyBP-C and MLC2
are likely to be important factors in determining radial
disposition of the heads of myosin.Journal of Biomedicine and Biotechnology 7
7. Sarcomeric Proteins as Targets for
Inotropic Agents
Potential application to rational drug design is a signiﬁcant
aspect of the understanding of the relations between cellular
and molecular mechanisms at the level of the sarcomeres.
There has been a long standing eﬀort to develop agents
that directly modify the sarcomere response to Ca2+ with
some success (see [42, 43] for reviews). Levosimendan and
pimobendan are examples of such agents, which progressed
into clinical use, and which are able to promote sarcomere
responsiveness to Ca2+ and demonstrate some therapeutic
beneﬁts in acute and chronic heart failure. However, these
agents have oﬀ target eﬀects and there is a need for agents
or approaches with more speciﬁc targeting to the sarcomeres
[42]. For example, both Levosimendan and Pimobendan
have been demonstrated to inhibit phosphor-diesterase III
in addition to directly aﬀecting Ca2+-signaling to TnC.
The identiﬁcation of the molecular processes involved in
maintenance of systolic elastance and as determinants of
isovolumic relaxation provides clues as to the location of
these targets. A recent apparent success in the search for
sarcomere activators has been the identiﬁcation of a com-
pounddevelopedbyCytokinetics,Inc(CK-1827452)directly
reacting with myosin and prolonging systolic elastance
(reviewed in [44]). Evidence for factors maintaining systolic
elastance summarized is thus signiﬁcant in translational
medicine, as these results with CK indicate that modiﬁcation
of systolic elastance is a viable pharmacological target.
Modiﬁcation of Tn, MLC2, MyBP-C or titin by drugs may
also be an important road to success, but has not been
explicitly investigated.
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